From left to right: Dr Andy Chevigné, Dr Martyna Szpakowska and Max Meyrath. Credit: LIH Novel molecule targets a newly discovered opioid receptor with atypical properties and holds promise for alternative therapeutic strategies. Researchers at the Department of Infection and Immunity of the Luxembourg Institute of Health (LIH) developed LIH383, […]